BEUDAMED
    96 results · 18ms · Sources: EU EUDAMED, US FDA
    Filters Classification: FDA Class 3 ×

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·UROLOGIX TARGIS SYSTEM FOT THE TREATMENT OF BPH

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH

    System, Hyperthermia, Rf/Microwave (Benign Prostatic Hyperplasia),Thermotherapy

    FDA Pre-Market Approval
    FDA Class 3 ·UROLOGIX TARGIS SYSTEM FOR THE TREATMENT OF BPH

    Intraocular Lens

    FDA Pre-Market Approval
    FDA Class 3 ·MODELS B-13F (P-10) & B-1H (P-11)

    Intraocular Lens

    FDA Pre-Market Approval
    FDA Class 3 ·1CDELS B-13F (P-10) & B-1H (P-11)

    Intraocular Lens

    FDA Pre-Market Approval
    FDA Class 3 ·MODELS B-13F (P-10) & B-1H (P-11)

    Intraocular Lens

    FDA Pre-Market Approval
    FDA Class 3 ·MODELS B-13F (P-10) & B-1H (P-11)

    Intraocular Lens

    FDA Pre-Market Approval
    FDA Class 3 ·MODELS B-13F (P-10) & B-1H (P-11)

    Intraocular Lens

    FDA Pre-Market Approval
    FDA Class 3 ·MODELS B-13F (P-10) & B-1H (P-11)

    Intraocular Lens

    FDA Pre-Market Approval
    FDA Class 3 ·MODELS B-13F (P-10) & B-1H (P-11)

    Intraocular Lens

    FDA Pre-Market Approval
    FDA Class 3 ·1CDELS B-13F (P-10) & B-1H (P-11)

    Intraocular Lens

    FDA Pre-Market Approval
    FDA Class 3 ·MODELS B-13F (P-10) & B-1H (P-11)